Cannabis and Opioid Use Disorder, Study 2
Key facts
- Who runs it
- University of Kentucky
- Where
- Lexington, United StatesSee the site
- Trial code
- Status
- Not yet recruiting
- Phase
- Phase 1
- People taking part
- 100 people, planned
- Starts
- 30 Nov 2026
- Expected to end
- 30 Jan 2030
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Inhaled Cannabis
- Intranasal Opioid
- Record updated
- 9 October 2026
Who can take part
- Age
- 18 years to 55 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Participants with moderate to severe opioid use disorder
Who cannot take part
- Individuals who do not use opioids or do not experience opioid withdrawal when they stop using opioids
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 55 years old?
Where in United States
- University of KentuckyLexington, United StatesContact: Paul NuzzoNot yet recruiting
About the trial
What the trial wants to find out
This inpatient study enrolls healthy individuals who have opioid use disorder. Participants live at the University of Kentucky Hospital for approx. 6 weeks. During this time, we will examine how repeated doses of oral cannabis and acute doses of oral and inhaled cannabis 1) modify the intensity and time course of opioid withdrawal, 2) modify the effects of intranasal opioid administration and 3) impact the safety of opioid administration.
The 2 groups in the trial
- Oral cannabis (placebo)Placebo, for comparison
Participants will receive placebo oral cannnabis
Treatment: Inhaled Cannabis and Intranasal Opioid
- Oral cannabis (active)Treatment being tested
Participants will receive active oral cannabis
Treatment: Inhaled Cannabis and Intranasal Opioid
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Criteria questions
- Built from NCT07661446, who can take part
- Record updated
- 9 October 2026